Program Overview

The University of Utah Health Care Thrombosis Service will host the first Biennial Western Regional Thrombosis Symposium and Working Group Session in 2010. The purpose of this one and a hald-day scientific and academic medical conference is to foster consensus building and collaboration amoung multidisciplinary Western Regional leaders, and to encourage scientific discovery and medical education with regard to thrombosis diagnosis, treatment and prevention in both clinical and research practices and health professional and public education outreach.

Our objective is to optimize patient care. To this end, the Symposium is designed to provide the most up-to-date information to assist with the implementation of evidence-based management strategies for patients with venous and arterial thrombotic diseases, such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, peripheral artertial disease, and stroke. The target audience includes community and hospital-based physicians, basic and translational scientists, pharmacists, physician assistants, nurses, administrators, and allied health professionals from throughout the Western Regional United States.

State-of-the-art interactive presentioanls, panel discussion, and "Breakfast With the Experts," will provide numerous opportunities attendees to discuss real patient cases with leaders in the field, network with colleagues, and gain knowledge that can impact practice strategies.

The Junior Faculty and Trainee Mentorship and Networking Luncheon is intended to provide 4th year medical students, pharmacy residents and students, junior faculty, clinicians and scientists interested in a career in thrombosis treatment and prevention, a unique opportunity to seek advice from established experts in the field and leanr valuable information about career planning and institutional resources.

11:30AM	12:00PM	Registration & Seating
12:00PM	12:10PM	Welcome & Introductions
12:10PM	12:30PM	Opportunities for Advanced Learning at the University of Utah
12:30PM	12:50PM	Getting Involved Nationally-North American Thrombosis Forum (NATF)
12:50PM	1:10PM	Young Investigator Presentation
1:10PM	2:00PM	Open Discussion: Participation identified assessment of skills, knowledge, and mentorship that will help navigate career path decision making and achieve successful career advancement.

The Western Thrombosis Working Group Session is a half-day, closed, working meeting, where leaders and innovators in thrombosis research, treatment and prevention convene to 1) identify gaps in current thrombosis research, clinical service, education, and career development, and 2) formulate recommendations for addressing those gaps. This dynamic meeting is intended to serve as a consensus building exercise that fosters collaboration amoung Western Regional institutions committed to improving thrombosis clinical research practice standards, competency, and encourage multidisciplinary career development.

2:00PM	2:30PM	Thrombosis Working Group Registration (Closed Session Begins)
2:30PM	3:00PM	Seating, Welcome and Introductions
3:00PM	3:15PM	Break into Thrombosis Working Groups
3:15PM	5:15PM	Group 1:Research-Task: identify specific strategies and priorities to enhance research networking
3:15PM	5:15PM	Group 2: Clinical Service-Task :Identify priorities, strategies, and metrics that would lead to improvement of the quality of care delivered to prevent or manage thrombotic disorder in Western United States
3:15PM	5:15PM	Group 3: Education-Task: Identify strategies and priorities to enhance educational formats, content and outreach in the Western United States for both patients and providers
3:15PM	5:15PM	Group 4: Career Development-Task: Identify specific and innovative strategies to enhance mentorship and career development of trainees, pharmacy residents and students, junior faculty, clinicians and scientists interested in thrombosis-related fields in the Western United States
5:15PM	7:00PM	Return to Plenary Session: Group Present Task Orders
7:00PM		Adjourn
7:00PM	9:00PM	Working Group Faculty Dinner

The objective of this 1-day Western Regional Thrombosis Symposium physician, nurse, and pharmacist continuing medical eduation Accredited program, is ot optimize patient care. To this end, this scientific and academic medical conference is designed to foster career development and encourage scientific discoveryand medical education and outreach. Content for this program is especially catered to the needs of multidisciplinary health professionals from through out the Western Regional United States.

6:30AM	7:30AM	Registraion & Breakfast with the experts: Open Forum Case Discussion
7:30AM	7:45AM	Seating
7:45AM	7:50AM	Welcome, Course Directors: Robert C. Pendleton,MD, Sara R. Vasquez, PharmD, Barry Sults, MD
7:45AM	8:00AM	Opening Remarks-John R. hoidal, Chair-Dept. of Medicine, The University of Utah, SLC, UT

Session 1: Research Focus

8:00AM	8:25AM	Bridging inflammation and Thrombosis: A Translational Science Perspective	Andrew Weyrich, PhD, Univ. of Utah, SLC
8:25AM	8:55AM	Briding Inflammation and Thrombosis: The Clinical Perspective	J. Brent Muhlestein, MD, Intermountain Medical Center, Murray, UT
8:55AM	9:25AM	Personalized Medicine: Pharmacogenomic Testing to Individualize Warfin Management	Jeffery L. Anderson, MD, Univ. of Utah, SLC, UT
9:25AM	9:40AM	Lecture Faculty Panelist Discussion, Q & A Session
9:40AM	10:00AM	Morning Break (20 minutes)

Session 2.1: Clinical Focus--Antiplatelet Therapy

10:00AM	10:30AM	Updates in the Use of Antiplatelet Therapy for Primary Prevention	Barry Stults, MD The University of Utah, SLC
10:30AM	10:55AM	Acute Stroke and TIA: Antithrombotic Management Update	Elaine Skalabrin, MD The Univ. of Utah, SLC
10:55AM	11:20AM	Patent Foramen Ovale: Mechanism of Stroke	Andrew Michaels, MD, The Univ. of Utah, SLC
11:20AM	11:35AM	Lecture Faculty Panelist Discussion, Q & A Session

Keynote Lecture

11:35AM	12:15PM	Getting Involved in a National Level: Public Awareness, Pubic Policy and the Charitable Spirit of North America	Samuel Z. Goldhaber, MD, Brigham & Women's Hospital, Boston, MA
12:15PM	1:00PM	Lunch Break (45 Minutes)

Session 2.2: Clinical Focus--Venous Thromboembolism

1:00PM	1:25PM	Update: Venous Thromboembolism in the Cancer Patient	George Rodgers, MD, PhD, Univ. of Utah, SLC, UT
1:25PM	1:50PM	Duration of Anticoagulation for Unprovoked VTE: How long is Enough?	David A. Garcia, MD, University of New Mexico Health Sciences Center, Albuquerque, NM
1:50PM	2:15PM	Chronic Thromboembolic Pulmonary Hypertension	C. Gregory Elliot, MD Intermountain Medical Ctr. Murray, Utah
2:15PM	2:30PM	Lecture Faculty Panelist Discussion, Q & A Session

Session 2.3: Clinical Focus--Anticoagulant Therapy Complications

2:30PM	2:55PM	Heparin-Induced Thromocytopenia:Update & Future Directions	George Rodgers, MD, PhD, Univ. of Utah, SLC, UT
2:55PM	3:20PM	Managing Complications of Anticoagulation Therapy: The Bleeding and Anticoagulant Patient	Thomas G. Deloughery, MD Oregon Health & Science University, Portland, OR
3:20PM	3:35PM	Lecture Faculty Panelist Discussion, Q & A Session
3:35PM	3:50PM	Afternoon Break, (15 Minutes)

Session 3: Education Focus

3:50PM	4:15PM	Peri-procedural Anticoagulation:Implementing Strategies When No Evidence Exists	Robert C. Pendelton, MD, The University of Utah, Salt Lake City, UT
4:15PM	4:40PM	VTE Prevention:Form Institutional QI Successes to National Interventions	Gregory Maynard, MD, MS, University of California, San Diego, CA
4:40PM	4:05PM	The Impact of Emerging Anticoagulants on AC Clinics: Is Your Clinic Ready?	Ann Wittkowsky, Pharm D, University of Washington Medical Center, Seattle WA
5:05PM	5:20PM	Lecture Faculty Panelist Discussion, Q & A Session
5:20PM	5:30PM	Wrap-up, Closing Remarks
5:30PM		Adjourn